A(

A&B (HK)

Description

A&B (HK)

Investor Profile

A&B (HK) has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • France (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does A&B (HK) frequently co-invest with?

GO CAPITAL
Europe, Bretagne, France, Rennes
Co-Investments: 1
CM
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 1
Newton Biocapital
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
Anaxago
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Mirae Asset
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Karista
Europe, Ile-de-France, France, Paris
Co-Investments: 1

What are some of recent deals done by A&B (HK)?

Acticor Biotech

Paris, Ile-de-France, France

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series BNov 6, 2019
Amount Raised: $7,749,106